Zhejiang Jiuzhou Pharmaceutical Hits Day High with Strong Intraday Surge

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has experienced a notable increase of 5.88% on July 10, 2026, reaching an intraday high of CNY 15.06. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.0% on the same day. Over the past week, Zhejiang Jiuzhou has shown a modest gain of 0.89%, while its one-month performance reflects a significant increase of 17.97%. However, the stock has faced challenges over the longer term, with a year-to-date decline of 17.49% and a three-year drop of 44.49%. The company operates within the Pharmaceuticals & Biotechnology sector and boasts a market capitalization of CNY 10,957 million. Key financial metrics include a price-to-earnings ratio of 17.00 and a return on equity of 7.28%. Additionally, the stock offers a dividend yield of 4.10%, indicating a commitment to returning value to shareholders despite recent profit declines. Overall, Zhejiang Jiuzhou's performance today highlights its resilience in a fluctuating market environment.